Case reportPeritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
Under a Creative Commons license
open access
Key words
peritoneal tuberculosis
psoriasis
psoriatic arthritis
ustekinumab
Abbreviations used
IL
interleukin
MDR
multidrug resistant
PsA
psoriatic arthritis
TB
tuberculosis
TNF
tumor necrosis factor
Cited by (0)
Funding sources: None.
Conflicts of interest: Maeve Lynch has received a research grant from Merck & Co. and has acted as an advisory board member for Novartis. The rest of the authors have no conflicts of interest to declare.
© 2017 Elsevier Inc.